Skip to main content

Table 4 Multivariate analysis of STAT3 polymorphisms on survival

From: Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab

Variable Hazard ratio 95% CI p
IPI score 2.792 1.407 - 5.544 0.003
STAT3 polymorphisms 2.787 1.346 - 5.773 0.006
B symptoms 0.420 0.210 - 0.839 0.014